Prevalence of intermittent claudication and its effect on mortality
- PMID: 7102362
- DOI: 10.1111/j.0954-6820.1982.tb01939.x
Prevalence of intermittent claudication and its effect on mortality
Abstract
The prevalence of symptoms of intermittent claudication and their association with 5-year mortality were examined in a population study in Finland. A number of 5738 men and 5224 women, aged 30-59 years, from 4 geographic areas of the country were studied. According to a structured interview, 2.1% of the men and 1.8% of the women reported typical symptoms of intermittent claudication. Claudication was most prevalent in East Finland and among persons with agricultural occupations. The symptoms were more frequent in diabetics and persons with symptoms and signs of coronary heart disease (CHD) than in persons without these diseases. High serum cholesterol and smoking were associated with these symptoms but high blood pressure was not. The risk of death from cardiovascular causes was nearly 3-fold in men with claudication compared to men without claudication. Symptoms of chest pain and smoking increased significantly the mortality risk of male claudicants. The validity of symptoms was poorer in women than in men and they were also less reliable predictors of death in women. A small part of the effect of claudication on mortality was due to its association with conventional CHD risk factors. However, after adjusting for symptoms and signs of CHD, claudication had no independent effect on mortality in men.
Similar articles
-
Intermittent claudication. A risk profile from The Framingham Heart Study.Circulation. 1997 Jul 1;96(1):44-9. doi: 10.1161/01.cir.96.1.44. Circulation. 1997. PMID: 9236415
-
A marked decline in the prevalence and incidence of intermittent claudication in Icelandic men 1968-1986: a strong relationship to smoking and serum cholesterol--the Reykjavik Study.J Clin Epidemiol. 1994 Nov;47(11):1237-43. doi: 10.1016/0895-4356(94)90128-7. J Clin Epidemiol. 1994. PMID: 7722559
-
Intermittent claudication in Quebec men from 1974-1986: the Quebec Cardiovascular Study.Clin Invest Med. 1991 Apr;14(2):93-100. Clin Invest Med. 1991. PMID: 2060193
-
Management of peripheral arterial disease and intermittent claudication.J Am Board Fam Pract. 2001 Nov-Dec;14(6):443-50. J Am Board Fam Pract. 2001. PMID: 11757887 Review.
-
The natural history of claudication: risk to life and limb.Semin Vasc Surg. 1999 Jun;12(2):123-37. Semin Vasc Surg. 1999. PMID: 10777239 Review.
Cited by
-
The PANDORA study: peripheral arterial disease in patients with non-high cardiovascular risk.Intern Emerg Med. 2011 Dec;6(6):509-19. doi: 10.1007/s11739-011-0511-0. Epub 2011 Feb 5. Intern Emerg Med. 2011. PMID: 21298363
-
Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension.Drugs. 2002;62(1):107-33. doi: 10.2165/00003495-200262010-00005. Drugs. 2002. PMID: 11790158 Review.
-
Treatment of hypertension in peripheral arterial disease.Cochrane Database Syst Rev. 2013 Dec 4;2013(12):CD003075. doi: 10.1002/14651858.CD003075.pub3. Cochrane Database Syst Rev. 2013. PMID: 24307487 Free PMC article.
-
Correlation between peripheral arterial disease and coronary artery disease using ankle brachial index-a study in Indian population.Indian Heart J. 2012 Jan-Feb;64(1):2-6. doi: 10.1016/S0019-4832(12)60002-9. Epub 2012 Mar 26. Indian Heart J. 2012. PMID: 22572416 Free PMC article.
-
The reliability of differentiating neurogenic claudication from vascular claudication based on symptomatic presentation.Can J Surg. 2013 Dec;56(6):372-7. doi: 10.1503/cjs.016512. Can J Surg. 2013. PMID: 24284143 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources